LDLR and cancer: This phenomenon is most likely associated to the whole metabolic rewiring of this peculiar cancer type, as TRAP1 silencing alone is able to partially reproduce the transition toward a drug-resistant phenotype with reduced FDPS and OSC expression and cholesterol synthesis, and increased LDLR expression.